IMU has a market cap of just $12m. Sanofi-Aventis now owns 100% of Merial, shareholder approved a day ago. IMU owns worldwide rights to technology which will secure IMU 5-6% royalties on sales in a $3bn market. IMU's leading vaccines especially PRSS are on the threshold of commercialisation. Why wouldn't S-A buy IMU rather than pay it royalties? Far cheaper!
I'm merely speculating so please DYOR
is news coming?, page-9
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $378.4M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.1¢ | $514.7K | 9.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 2205822 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1542919 | 18 |
View Market Depth
| Last trade - 13.42pm 31/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |